Unloved chemicals company Synthomer (LON:SYNT) delivered ‘strong growth’ in sales and EBITDA in the first five months of 2026. Long-suffering investors were relieved to hear Q2 margins and EBITDA growth exceeded management’s expectations. Strong H1 trading and the benefits from self-help measures underpin the polymer group’s confidence in delivering ‘year-on-year progress’ in FY26. What does … Continue reading Synthomer boosted by ‘strong’ trading and self-help